<SEC-DOCUMENT>0000950170-22-026298.txt : 20221209
<SEC-HEADER>0000950170-22-026298.hdr.sgml : 20221209
<ACCEPTANCE-DATETIME>20221209161554
ACCESSION NUMBER:		0000950170-22-026298
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20221208
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221209
DATE AS OF CHANGE:		20221209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		221454963

	BUSINESS ADDRESS:	
		STREET 1:		10170 CHURCH RANCH WAY
		STREET 2:		SUITE 100
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80021
		BUSINESS PHONE:		7209402200

	MAIL ADDRESS:	
		STREET 1:		10170 CHURCH RANCH WAY
		STREET 2:		SUITE 100
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>abio-20221208.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2022-12-09T15:21:52.0316+00:00 --><!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:abio="http://www.arcabiopharma.com/20221208">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_409d6f5d-4f60-4aaf-a4b1-ecbafe5b2d43" name="dei:EntityCentralIndexKey" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266">0000907654</ix:nonNumeric><ix:nonNumeric id="F_31d121d9-d90f-4663-b282-fe97fb044b7c" name="dei:AmendmentFlag" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="abio-20221208.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000907654</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-08</xbrli:startDate><xbrli:endDate>2022-12-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_39567cc6-4808-418c-8a9f-e7a07f3c6c1a" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Report (Date of earliest event reported): December 9, 2022 (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c5240ab9-cea3-4f3a-b3d5-5768d6a9a40a" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 08, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d11a8935-1f3c-4234-898e-412bcd1fbe1b" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_dfe7e716-a952-4ed8-b17b-293c950ec8dd" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1daac4ad-bad2-48e2-a09e-89bf2d4da36f" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-22873</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f56d7869-33b8-45ba-a0bb-849a92d829f3" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36-3855489</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_37877fc7-21f9-46a1-9bf2-f5e1bc03dc19" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10170 Church Ranch Way</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d3486642-b598-479b-afab-6890711b0ede" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_db825c93-60be-4dc2-b218-594c3ab00ebe" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Westminster</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1de6beae-a2f6-49e1-a458-9e000a58d0ba" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Colorado</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_37632bb9-fcb2-4548-a9c8-0512deddcc4b" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80021</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_92e011be-4473-4f84-b915-9ed895858baf" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(720)</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_010c9a1a-4f89-42fa-bde5-718a4f657de9" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">940-2200</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7069f446-2682-4e08-ab7f-5f3bec47eb62" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_db840803-c813-4c76-b015-b7a305a95620" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a97a9c40-620e-4676-92d7-d69b27a4c4ac" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_be1c5693-cfbc-4fd7-960b-2fc5171da046" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_af9eccf7-60b8-49fd-9280-28a4e81cb463" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_33b05de7-82b2-45ee-9726-c23ac13c93be" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ABIO</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_82ea87fd-9124-4f04-9002-e69157ca4c2a" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The NASDAQ Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_64e6d3d6-4470-44ef-a06f-abed0342e111" contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double rgba(0,0,0,1);text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 8, 2022, the Compensation Committee (the &#x201c;Compensation Committee&#x201d;) of the Board of Directors (the &#x201c;Board&#x201d;) of ARCA biopharma, Inc. (the &#x201c;Company&#x201d;) approved retention bonuses, subject to continued employment with the Company through the earlier of a change in control of the Company or certain clinical development decisions, and granted the following restricted stock unit (&#34;RSUs&#34;) grants to the executive officers listed below pursuant to the Company&#x2019;s 2020 Equity Incentive Plan (the &#x201c;2020 Plan&#x201d;):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:57.469%;"></td>
    <td style="width:1.682%;"></td>
    <td style="width:1.682%;"></td>
    <td style="width:14.198%;"></td>
    <td style="width:4.861%;"></td>
    <td style="width:2.099%;"></td>
    <td style="width:2.948%;"></td>
    <td style="width:15.062%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name and Title</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Retention Bonus</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;RSUs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;Granted </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.221pt;white-space:pre-wrap;font-weight:bold;font-size:6.03pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
   </tr>
   <tr style="height:13.5pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas A. Keuer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Operating Officer</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,000</span></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,000</span></p></td>
   </tr>
   <tr style="height:13.5pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">C. Jeffrey Dekker</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,000</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,000</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)           Each RSU vests one year from December 8, 2022, subject to continuing employment with the Company through that date. In the event of a change in control of the Issuer or the grantee&#x2019;s involuntary termination without cause or by the grantee for good reason, 100% of the unvested RSUs shall become fully and immediately vested upon the closing date of such change in control or such involuntary termination date, respectively (to the extent such unvested RSUs have not yet then vested).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9 &#x2014; Financial Statements and Exhibits</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.01. Financial Statements and Exhibits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d) Exhibits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11.12%;"></td>
    <td style="width:10.056%;"></td>
    <td style="width:78.824%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="abio-ex10_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Memorandum Regarding Cash Retention Bonus between ARCA biopharma, Inc. and Thomas A. Keuer dated December 8, 2022</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="abio-ex10_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Memorandum Regarding Cash Retention Bonus between ARCA biopharma, Inc. and C. Jeffrey Dekker dated December 8, 2022</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (embedded within the inline XBRL document).</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.0%;"></td>
    <td style="width:44.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA biopharma, Inc.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Registrant)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 9, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ C. Jeffrey Dekker</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name: C. Jeffrey Dekker <br />Title: Chief Financial Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></span>&#160;</p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>abio-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img205126077_0.jpg" alt="img205126077_0.jpg" style="width:214px;height:77px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:14.0pt;font-family:&quot;Tahoma&quot;, sans-serif;font-style:italic;min-width:fit-content;">MEMORANDUM</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">To:  	Thomas A. Keuer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">From:  	Michael Bristow</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Date:	December 8, 2022</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Re:	Retention bonus</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In recognition of your continued service with ARCA biopharma, Inc. (the &#x201c;Company&#x201d;), we are pleased to offer you the opportunity to receive a cash retention bonus in the amount of</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$100,000</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> less applicable withholdings and deductions required by law (the &#x201c;Retention Bonus&#x201d;).  This Retention Bonus will be processed and paid to you by the Company via payroll within thirty (30) business days following the earlier to occur of either of the following (the date of occurrence of such event, the &#x201c;Payment Event Date&#x201d;), subject to the terms of this letter: (i) a Corporate Transaction (as defined below), or (ii) the date that the board of directors of the Company (the &#x201c;Board&#x201d;) approves certain clinical development decisions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to receive the Retention Bonus, you must (i) remain actively and continuously employed in good standing by the Company through the Payment Event Date, and (ii) otherwise comply with the terms and conditions of this letter and the Company&#x2019;s policies and procedures. In order to be considered in &#x201c;good standing,&#x201d; you must have been employed continuously from the date hereof to the Payment Event Date and you must not be the subject of any disciplinary warning, whether written or oral and must not have behaved in a manner that would be grounds for discharge for &#x201c;Cause&#x201d; (as defined below).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neither the Retention Bonus nor this letter have any bearing on your right to employment with the Company. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Your employment remains at-will, meaning that you and the Company may terminate the employment relationship at any time, with or without cause or reason, and with or without notice.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  You understand and agree that neither your job performance nor promotions, commendations, bonuses or the like from the Company give rise to or in any way serve as the basis for modification, amendment, or extension, by implication or otherwise, of your at-will employment with the Company. Although your job duties and the Company&#x2019;s personnel policies and procedures may change from time to time, the &#x201c;at-will&#x201d; nature of your employment may only be changed in an express written agreement or memo issued by the Company. For clarity, should</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4880-2506-7071.4 - 11/29/2022 3:38:11 PM</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">your employment terminate for any reason prior to the Payment Event Date, you will not have earned, and therefore will not receive, the Retention Bonus.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of this letter agreement, &#x201c;Cause&#x201d; means you have committed or engaged in: (i) misconduct, negligence, theft, fraud, or other illegal or dishonest conduct, any of which are considered to be harmful or potentially harmful to the Company; (ii) refusal, unwillingness, failure, or inability to perform material job duties or habitual absenteeism; (iii) violation of fiduciary duty, violation of any duty of loyalty, or breach of any material term of any agreement between you and the Company; or (iv) violation of any Company policy.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of this letter agreement, &#x201c;Corporate Transaction&#x201d; means (i) a sale of all or substantially all of the assets of the Company; (ii) a merger, consolidation or reorganization involving the Company if, immediately after the consummation of such merger, consolidation or reorganization, the stockholders of the Company immediately prior thereto do not own, directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving entity in such merger, consolidation or reorganization or (B) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation or similar transaction; or (iii) any transaction (including without limitation a merger or reorganization in which the Company is the surviving entity) which results in any person or entity (other than persons who are stockholders or affiliates of the Company immediately prior to the transaction) owning fifty percent (50%) or more of the combined voting power of all classes of stock of the Company, other than the sale by the Company of stock in transactions the primary purpose of which is to raise capital for the Company&#x2019;s operations and activities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This letter contains the entire agreement regarding this subject matter and supersedes in their entirety any prior or contemporaneous agreements between you and the Company regarding retention bonuses or payments, whether written, oral, express or implied.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Agreement may not be amended or modified unless in writing signed by both you and an authorized officer of the Company. This Agreement, for all purposes, shall be construed in accordance with the laws of the State of Colorado without regard to conflicts-of-law principles.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sincerely,</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA BIOPHARMA, Inc.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:/s/ Michael Bristow</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Dr. Michael Bristow</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4880-2506-7071.4 - 11/29/2022 3:38:11 PM</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACCEPTED AND AGREED:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By: /s/ Thomas A. Keuer</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thomas A. Keuer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	Date: December 8, 2022</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">Confidential</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4880-2506-7071.4 - 11/29/2022 3:38:11 PM</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>abio-ex10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html>
 <head>
  <title>EX-10.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img206049598_0.jpg" alt="img206049598_0.jpg" style="width:214px;height:77px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:14.0pt;font-family:&quot;Tahoma&quot;, sans-serif;font-style:italic;min-width:fit-content;">MEMORANDUM</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">To:         Jeff Dekker</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">From:  	Michael Bristow</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Date:	December 8, 2022</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Re:	Retention bonus</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In recognition of your continued service with ARCA biopharma, Inc. (the &#x201c;Company&#x201d;), we are pleased to offer you the opportunity to receive a cash retention bonus in the amount of</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$100,000 less applicable withholdings and deductions required by law (the &#x201c;Retention Bonus&#x201d;).  This Retention Bonus will be processed and paid to you by the Company via payroll within thirty (30) business days following the earlier to occur of either of the following (the date of occurrence of such event, the &#x201c;Payment Event Date&#x201d;), subject to the terms of this letter: (i) a Corporate Transaction (as defined below), or (ii) the date that the board of directors of the Company (the &#x201c;Board&#x201d;) approves certain clinical development decisions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to receive the Retention Bonus, you must (i) remain actively and continuously employed in good standing by the Company through the Payment Event Date, and (ii) otherwise comply with the terms and conditions of this letter and the Company&#x2019;s policies and procedures. In order to be considered in &#x201c;good standing,&#x201d; you must have been employed continuously from the date hereof to the Payment Event Date and you must not be the subject of any disciplinary warning, whether written or oral and must not have behaved in a manner that would be grounds for discharge for &#x201c;Cause&#x201d; (as defined below).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neither the Retention Bonus nor this letter have any bearing on your right to employment with the Company. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Your employment remains at-will, meaning that you and the Company may terminate the employment relationship at any time, with or without cause or reason, and with or without notice.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  You understand and agree that neither your job performance nor promotions, commendations, bonuses or the like from the Company give rise to or in any way serve as the basis for modification, amendment, or extension, by implication or otherwise, of your at-will employment with the Company. Although your job duties and the Company&#x2019;s personnel policies and procedures may change from time to time, the &#x201c;at-will&#x201d; nature of your employment may only be changed in an express written agreement or memo issued by the Company. For clarity, should</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4880-2506-7071.4 - 11/29/2022 3:38:11 PM</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">your employment terminate for any reason prior to the Payment Event Date, you will not have earned, and therefore will not receive, the Retention Bonus.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of this letter agreement, &#x201c;Cause&#x201d; means you have committed or engaged in: (i) misconduct, negligence, theft, fraud, or other illegal or dishonest conduct, any of which are considered to be harmful or potentially harmful to the Company; (ii) refusal, unwillingness, failure, or inability to perform material job duties or habitual absenteeism; (iii) violation of fiduciary duty, violation of any duty of loyalty, or breach of any material term of any agreement between you and the Company; or (iv) violation of any Company policy.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of this letter agreement, &#x201c;Corporate Transaction&#x201d; means (i) a sale of all or substantially all of the assets of the Company; (ii) a merger, consolidation or reorganization involving the Company if, immediately after the consummation of such merger, consolidation or reorganization, the stockholders of the Company immediately prior thereto do not own, directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving entity in such merger, consolidation or reorganization or (B) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation or similar transaction; or (iii) any transaction (including without limitation a merger or reorganization in which the Company is the surviving entity) which results in any person or entity (other than persons who are stockholders or affiliates of the Company immediately prior to the transaction) owning fifty percent (50%) or more of the combined voting power of all classes of stock of the Company, other than the sale by the Company of stock in transactions the primary purpose of which is to raise capital for the Company&#x2019;s operations and activities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This letter contains the entire agreement regarding this subject matter and supersedes in their entirety any prior or contemporaneous agreements between you and the Company regarding retention bonuses or payments, whether written, oral, express or implied.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Agreement may not be amended or modified unless in writing signed by both you and an authorized officer of the Company. This Agreement, for all purposes, shall be construed in accordance with the laws of the State of Colorado without regard to conflicts-of-law principles.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sincerely,</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARCA BIOPHARMA, Inc.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:/s/ Michael Bristow</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Dr. Michael Bristow</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4880-2506-7071.4 - 11/29/2022 3:38:11 PM</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACCEPTED AND AGREED:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:/s/Jeff Dekker</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jeff Dekker</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	Date: December 8, 2022</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;font-style:italic;min-width:fit-content;">Confidential</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"></font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4880-2506-7071.4 - 11/29/2022 3:38:11 PM</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img205126077_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img205126077_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #/ CD# 2(  A$! Q$!_\0
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M2"/(5C*WJ!M7_$_I7D5L/)*\E;U.F,T]C+D6MCPI_P AAO\ KDW\Q69*2<]
M/05J>%?^0PW_ %R;^8K' JV,I^I=9_NF=K1117WIXX4444 %%%% !6-XKUD:
M#X:O+\,!*J;(?>0\+^O/X5LUY#\7=:\Z^M=&B?Y8!YTP']\CY1^ R?\ @5 %
M+X8>'TUC4;^[NTWV\<#0\]VD!!_\=W?F*XG4+*73M1N;*88D@D:-N.I!QFO>
MO &C_P!C^$+1'7$UP/M$OU;I^2[17G/Q8TG[%XFCOT7$=[$"3CC>O!_3:?QH
M Q/ ^L?V+XMLKAFVPR-Y$O/&UN,GZ'!_"OHBOE6OH[PAJ_\ ;?A:QO6;=*8]
MDOKO7@G\<9_&@#<HHHH **** "BBB@#G_''_ ").K?\ 7 _S%?.M?17CC_D2
M=6_ZX'^8KYUH [7X5_\ ([1_]<)/Y5[K7A7PK_Y':/\ ZX2?RKW6@ HHHH Y
MWQVBR>"-55N@AW?B&!'\J^=Z^@OB)<BV\#:D2<&15C4>N6 _EFOGV@#=\%R-
M%XTTAEZFY5?P/!_0U]&UX)\-=+?4?&5M+MS%: SR'TP,+^I'Y&O>Z "H;NZA
ML;.:ZN'"0PH7=CV &34U>=_%K63::);Z7$V'O'W28_N+@X_$D?D: /+_ !'K
ML_B+6Y]0G) 8[8D)_P!6@Z+_ )[YJC864^HW\%E;+NFG<(@]R?Y57KT7X1Z0
M+G6[G4Y%RMI'LCS_ 'WR,_\ ?(/YT >K:+I-OH>D6VG6P_=PK@MW9N['W)YJ
M_110 4444 %%%% !4=Q;Q75M+;S('BE0HZGN",$5)10!YG\//#>L>'O$^I)=
M6LB61B9%F)&'(<;2.>XR:],HHH **** "BBB@"*YN(K2UEN9FVQ1(7=O0 9-
M>%>'HI?&?Q%6YN5RCS&YE4\X1>B_3[JUWWQ5UK^S_#B:?&^)KY]IP>1&O+?F
M=H_$U3^$6C^1I5UJTB_/<OY41/\ <7J?Q;C_ (#0!P/CS2O[(\87T2KB*9O/
MC^C\G\CD?A6'8WDNGW]O>0'$L$BR+]0<UZO\7]*\W3;+547YH',,A']UN0?P
M(_\ 'J\@H ^HK&\BU"PM[R$YBGC61?H1FK%<%\*-7^W>&I-/=LRV,F!_N-DC
M]=P_ 5WM !1110 4444 >:S#_2YO]]OYU+&*;(I:[FQC_6-U('>K,-N[D &/
M/_71?\:_/80;D[(]IM)#XQ6K97\]MA0VZ/\ N-_3TJ"#3+F3&!'_ -_%/\C6
MA%HUQ_&\:_B37LX6AB(OF@FCEJ3@]&S0ADM+T9,:[^X(YK*UNY6 +80?*I^:
M3!_(?Y]JTH-,$3J[2[B#G &*YC4I"^L7);L^W\N/Z5VYA5J4\.N96E)V^1E1
MBI3TV1/;K6G F<5EV[=*TX'QBN;"6+J&C'"".E0S1[>1P:E2; ZU#-*"#7JS
M<.0YU>Y9A2*[0/*@9U^4U#<7T%H"MO&A?V& *98$2/-$3PR_Y_G1)I!;[DH_
M$4.525-2I+7J^H6BI6DS%N[B6Y?=*Y;T'850D%;DVC7(!(,9'^]C^=9T^GW"
M?>$?_?U?\:\+$X>M=N46==.<=DS*D%:?A;_D,M_UR;^8JC+"R]2GX2*?ZU?\
M,#&M,#C_ %3=#GN*X\'%K%T[]S6J_P!TSLZ***^Y/)"BBB@ HHHH ANKF*RM
M)KJ=ML4*&1V] !DUX!ID,WC/QXAG!(N[@RRC^[&.2/\ OD8'X5Z/\5M;^P>'
MH]-B;$U\^&QVC7!/YG:/SK*^#^CXCOM9D7[Q^SQ$^G!;_P!E_(T >I@8&!TK
MC?B;I/\ :7A"69%S+9.)UP.=O1OPP<_A795'/#'<V\D$JAHY%*.I[@C!% 'R
MS7J/P?U?9/?:/(W#@7$0]Q@-^FW\C7G6JZ?)I6K7=A+G?;RM'DCJ >#^(YJQ
MX;U5M$\16.H G;%*-^.Z'AA^1- 'TM12*RNH92"I&01W%+0 4444 %%%% '/
M^./^1)U;_K@?YBOG6OHKQQ_R).K?]<#_ #%?.M ':_"O_D=H_P#KA)_*O=:^
M=O!>O6OASQ$FH7D<SPB-D(A +9(]R*]13XK^&GSDWB8_O0]?R- '<45PD_Q:
M\.Q ^7'?3'MMB _FPKD]=^+&HWT+6^EVPL4;@REM\F/;C"_K]: +?Q9\11W,
MT&AVSAA WFW!!X#XPJ_@"2?J/2O.;*RN=1O(K2SA::>5MJ(HY/\ GUKJ=#^'
M6OZY(L]S&;.W<[FFN<[VSW"]2?KCZUZYX;\)Z9X8MRMG&7G<8DN).7?V]A["
M@"'P9X6B\+:/Y!*O>3$/<2#N>RCV']2>]='110 5X3\4KXW?C26'.5M8DB'X
MC<?_ $+]*]VKYR\:2-+XSU=FZBY9?P' _E0!A5[G\*K,6W@Q9\<W4[R9]A\G
M_LIKPROHCP'&(_ ^E*.AB+?FQ/\ 6@#HJ*** "BBB@ HHHH **** "BBB@ H
MHHH ***PO&&M?V#X7O+Q6VS%?+A]=[< _AU_"@#Q[QSJDGB/QK+%;9D2-Q:6
MZCN0<''U8G]*]QT?3H](T>TT^+&VWB"9'<]S^)R?QKQCX7Z/_:7BM;J1<PV*
M^<<]"YX7]<G_ (#7NE &;X@TQ=9T"^T\@9GB(3/9NJG\P*^:&5D8JP(93@@]
MC7U37S_\1-*_LKQE=A5Q%<XN4_X%][_QX-0!+\-=7_LOQ?!&[8AO ;=L^IY7
M_P > 'XU[W7RO'(\4J21L5="&5AU!'0U],:%J::SH5EJ*8_?Q!F [-T8?@01
M0!H4444 %%%% 'FTO_'W-_OM_.I8ZAF/^F3?]=&_G4D9K\[B_>9[3V+L=789
M73[CLOT.*J6L,MP^R)&<^W:M>"UM+;F[N%9Q_P LT.<?7%>OA:<Y:K1=]D<U
M226A9L);N5UPS,@/S%O2N?UJ(VVM39Z2$.OOG_Z^:Z3^UHE 6&(X'3/ JMJ=
MBVL6"S(@6XC)V?[0]*[\715;#\E.7-):_P# ,:<N6=Y*R9A0R=*OQ3>]8B.T
M;E'!5@<$$8(-6DG]Z\>AB+'5.%S:$_'6F//D=:SA<>]2VZ2WDPBB&2>I[ >I
MKN6)<_=CJS+D2U9LZ2KM'/*G4C:I/K_G%5[FXND<K))(I],XJ\\O]F1QP)'N
M0+U/&3WICZA9W";+B-@/7&<5Z<HQ5-4W.TE]QSIMRYK:&',[-]YB?J:IR5KW
M%@L@+6<RS#^YGYA^%8\P*L58$$=0:\/$PE!^\==-I[%:2M+PO_R&6_ZY-_,5
MER&M/PM_R&6_ZY-_,5RX)_[73]32K_"9VM%%%?=GD!1110 445@>,]:_L'PM
M>7:-MG9?*@]=[< CZ<G\* /&_'VM_P!M^++J1&W6]N?L\..F%/)_$Y/Y5N:#
M\3XM!T2UTR'0]ZP+@O\ :\;V)R3C9QDDUC?#[1$USQ7 D\2RVMN#/,KC*L!T
M![')(X],U[7_ ,(QX?\ ^@%IG_@)'_A0!Y__ ,+G_P"H!_Y.?_84?\+G_P"H
M!_Y.?_85Z!_PC'A__H!:9_X"1_X4?\(QX?\ ^@%IG_@)'_A0!X)XIUV/Q)K;
MZE'9?9&D15=/,W[F'&<X'; _"L6O<?'?A+39/"5W+IVF6EO<VV)PT$"H2J_>
M&0.FW)Q["O#J /H#X=ZO_:_@^UWMNFM?]'DS_L_=_P#'2/UKJJ\7^$NK_9-?
MGTR1L1WD>4'^VF3_ .@[OR%>T4 %%%% !1110!S_ (X_Y$G5O^N!_F*^=:^B
MO''_ ").K?\ 7 _S%?.M '4> -(L=;\4)9ZC!YUN8G8IO9>0..5(->GW?PN\
M,7$96&VFM6QPT4[''_?1->>_"O\ Y':/_KA)_*O=: /G;Q9X2O/"M^L<K>=:
MRY,,X& WJ".Q%<]7TMXBT.W\0Z+/I]P -XS&^.8W'1O\]LU\XWUE<:;?3V5T
MA2>%RCK[C^E 'L'PP\5?VEIW]C7<F;NU7]TS'F2/T^J]/ICWKT*OE_3=0N=*
MU&"^M'V3PN&4_P!#['I7T=H.M6VOZ-;ZC;'Y9!\Z9Y1AU4_3_P"O0!I4444
M%?.GC:(P^-=64][@M^?/]:^BZ\.^*U@;7QA]IQ\MW CY]U^4C\E'YT <-7T-
MX F$W@;2F&.(V3C_ &68?TKYYKVOX27XN/#$]F3\]K<'C_989'Z[J ._HHHH
M **** "BBB@ HHHH **** "BBB@ KQWXN:U]HU6VT>)\I:KYDH!_C8< _1?_
M $*O6[V\AT^QGO+AML,$;2.?8#-?.D*7/BOQ8JL3YU_<Y8CG:">?P _E0!M>
M#_'<7A/3Y[==)^TRS2;WE^T;. , 8VGIS^=='_PN?_J ?^3G_P!A7?+X6\/H
MBJ-#TT@#&3:H3^>*=_PC'A__ * 6F?\ @)'_ (4 >?\ _"Y_^H!_Y.?_ &%<
MKXR\91^+A:-_9GV26WW#?Y^_<IQQC:/3^=>U?\(QX?\ ^@%IG_@)'_A574?!
M^AWFFW-M%I.GP2RQ,J2QVR*R,1P00.QH ^=*]>^$&K^;I]YI$C?- WG1 _W6
MX8?@<?\ ?5>22Q/!,\,JE9$8JRGL1P16]X(U?^Q?%ME<,VV&1O)E]-K<?H<'
M\* /HFBBB@ HHHH \SN#B\F_WV_G4T3HO)7<??@5!=?\?<W^^W\Z(VK\W4K3
M9[EKHTQ=2NFPOA/[B\#\A4B-5!&JY;(T\@1,>I)X 'J?:O0I5)3:6[,9)(U+
M"W:[F"C(0<L?05K7%_%;CRH0&8<<=%K(>_6&'[-:$A/XI.A<_P!!5='S@"O8
MIXE48\E/?J_\CE<')W>QLRZ9;:M;K+<1[92/]8G!_P#KUF?\(R6)-O?*RCU7
MI^1K7O)_L=G' I^<KCZ#O46D29DD3U /^?SKHJX?#5:L85(WEU>VOR(C.I&+
M:>A3@\.1+*$GO-S?W$&#6A+LTM(TMHE5#R?4_C5*ZN&6_D=3@JV!^'%6[Z1;
MK3%G3^$@D>G8T4HT:<9JBK277K;YA)RDUS/1DQ>'4K<H#MD'(!Z@U@3AHI&C
M<893@BD\YHV#(Q5AT(JQ+.FI1@-A;M1@'H)!Z?6N6M76(CKI)?C_ ,$TC!P?
MD9KM@Y!J.6[D<8E(D Z;^2/QZTV1L$@\&JSM7C5*K6S.J,1DI7MD>QK4\*?\
MAAO^N3?S%8SMDUL^%/\ D,-_UR;^8J,!*^,I^HZR_=,[:BBBOOCQPHHHH *\
M;^+>M?:=7M](B?,=HOF2@?\ /1NGY+C_ +Z->N7][#IVGW%[<'$4$;2.?8#-
M?-LCW?B'7RQ^:ZOKC@?[3-P/H,T >M?";1_L?AZ74I%Q+>R?*2/^6:Y _7=^
ME>@56T^RBT[3K>R@&(H(UC7Z 8JS0 4444 -DC26-HW4,C JRGH0:^9]=TQM
M&UV]TYL_N)2JD]UZJ?Q!!KZ:KQ[XO:3Y&JV>JQKA;A#%(1_>7H3]0<?\!H X
M#3+^72]4M;Z'_66\JR >N#T_'I7TW:W,5Y:0W4#;HID61#ZJ1D5\M5[C\+-7
M_M#PM]C=LS6+F/D\[#RI_F/^ T =S1110 4444 <_P"./^1)U;_K@?YBOG6O
MHKQQ_P B3JW_ %P/\Q7SK0!VOPK_ .1VC_ZX2?RKW6O"OA7_ ,CM'_UPD_E7
MNM !7F7Q5\+_ &BV77[5/WL("7('\2=F_#I],>E>FTR6*.>%X94#QR*596'!
M!X(- 'RQ79?#OQ4?#^LBUN9,:?=L%DR>(W[/_0^WTK,\8>')/#6O2VF&-L_[
MRW<]T/;ZCH?_ *]8% 'U517 _#/Q7_:^F?V5=R9O;1?D9CS)'T!^HZ'\/>N^
MH *X+XK:*=0\.1ZA$N9;%]S8_P">;8#?D=I_ UWM,FACN()()D#Q2*4=3T8$
M8(H ^6*[;X8:T-+\4BUE?;!?+Y1STW]4/\Q_P*L;Q9X=F\-:Y+9L"8&^>WD/
M\2'I^(Z&L-':-U=&*LIR"#@@T ?5-%<[X,\31^)M#CG+ 7D0"7*#LW][Z'K^
M8[5T5 !1110 4444 %%%% &;KFN67A[36O[]F$08( @RS,>P'YG\*ETG5+?6
M=+@U"TW^1,"5WKM/!(.1]17C?Q,\3+K6M"PM9 UG9$KN4\/)_$?<#H/Q]:]A
MT.Q_LW0;"RQ@P6Z(P_V@!G]<T :%%%% 'GOQ9UK['H4.EQMB6]?+X/2->?U.
M/R-8'PBT?S]5NM6D7Y+9/*C)_OMU(^B\?\"KF/'&M_V[XJN[A&W6\1\B'!R-
MB]Q]3D_C7LO@71_[%\)64#+MFE7SY?7<W//T&!^% '1T444 %%%% '@OQ+TG
M^S/&$\J#$5XHN%^IX;]03^-<?7M?Q9TG[9X<BU!%S)92?,?]AN#^NW]:\4H
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M$9D4#'&<9(&?PS0!>HKC- U>^EU:."69YHY<A@W.."<CTKLZ "BBB@ HHHH
M**** "BBB@ HHHH ***RM;.I);/-931QQQH6D!'S''I^% %^YNH+2/S+B58U
M]6/6I@00".AKSBS2;5=5@CFD>4NXW%CD[>I_3->C]!@4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX:ZMH ?N(7/XG_ZU %KP<I%G<OSM,@ ^H'_UZZ6L[0[,V.DPQ,,2,-[CW/\
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img206049598_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img206049598_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #/ CD# 2(  A$! Q$!_\0
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M2"/(5C*WJ!M7_$_I7D5L/)*\E;U.F,T]C+D6MCPI_P AAO\ KDW\Q69*2<]
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MU&"^M'V3PN&4_P!#['I7T=H.M6VOZ-;ZC;'Y9!\Z9Y1AU4_3_P"O0!I4444
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M^S/&$\J#$5XHN%^IX;]03^-<?7M?Q9TG[9X<BU!%S)92?,?]AN#^NW]:\4H
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M$9D4#'&<9(&?PS0!>HKC- U>^EU:."69YHY<A@W.."<CTKLZ "BBB@ HHHH
M**** "BBB@ HHHH ***RM;.I);/-931QQQH6D!'S''I^% %^YNH+2/S+B58U
M]6/6I@00".AKSBS2;5=5@CFD>4NXW%CD[>I_3->C]!@4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX:ZMH ?N(7/XG_ZU %KP<I%G<OSM,@ ^H'_UZZ6L[0[,V.DPQ,,2,-[CW/\
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>abio-20221208.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-12-09T15:21:51.5518+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.arcabiopharma.com/20221208" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:abio="http://www.arcabiopharma.com/20221208" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20221208_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abio-20221208_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>abio-20221208_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-12-09T15:21:51.6061+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="abio-20221208.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>abio-20221208_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-12-09T15:21:51.5917+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140187693165392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 08, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  08,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARCA biopharma, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000907654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">000-22873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-3855489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10170 Church Ranch Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Westminster<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">940-2200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABIO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>abio-20221208_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abio-20221208.xsd" xlink:type="simple"/>
    <context id="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000907654</identifier>
        </entity>
        <period>
            <startDate>2022-12-08</startDate>
            <endDate>2022-12-08</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_409d6f5d-4f60-4aaf-a4b1-ecbafe5b2d43">0000907654</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_31d121d9-d90f-4663-b282-fe97fb044b7c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_39567cc6-4808-418c-8a9f-e7a07f3c6c1a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_c5240ab9-cea3-4f3a-b3d5-5768d6a9a40a">2022-12-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_d11a8935-1f3c-4234-898e-412bcd1fbe1b">ARCA biopharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_dfe7e716-a952-4ed8-b17b-293c950ec8dd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_1daac4ad-bad2-48e2-a09e-89bf2d4da36f">000-22873</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_f56d7869-33b8-45ba-a0bb-849a92d829f3">36-3855489</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_37877fc7-21f9-46a1-9bf2-f5e1bc03dc19">10170 Church Ranch Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_d3486642-b598-479b-afab-6890711b0ede">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_db825c93-60be-4dc2-b218-594c3ab00ebe">Westminster</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_1de6beae-a2f6-49e1-a458-9e000a58d0ba">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_37632bb9-fcb2-4548-a9c8-0512deddcc4b">80021</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_92e011be-4473-4f84-b915-9ed895858baf">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_010c9a1a-4f89-42fa-bde5-718a4f657de9">940-2200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_7069f446-2682-4e08-ab7f-5f3bec47eb62">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_db840803-c813-4c76-b015-b7a305a95620">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_a97a9c40-620e-4676-92d7-d69b27a4c4ac">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_be1c5693-cfbc-4fd7-960b-2fc5171da046">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_af9eccf7-60b8-49fd-9280-28a4e81cb463">Common</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_33b05de7-82b2-45ee-9726-c23ac13c93be">ABIO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_82ea87fd-9124-4f04-9002-e69157ca4c2a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266"
      id="F_64e6d3d6-4470-44ef-a06f-abed0342e111">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #Y@8E5.JJBYT !   \ @
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MZ7FFUS>36TGHX-R#8._AE8P=S8\?=_<#4$L#!!0    ( /F!B54D'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ^8&)50^^W0;N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M^8&)59E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " #Y@8E5;!>>560$   F$0  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M^8&)59^@&_"Q @  X@P   T              ( !IPP  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " #Y@8E5EXJ[',     3 @  "P              @ &#
M#P  7W)E;',O+G)E;'-02P$"% ,4    " #Y@8E5.JJBYT !   \ @  #P
M            @ %L$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ^8&)
M520>FZ*M    ^ $  !H              ( !V1$  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ ^8&)5660>9(9 0  SP,  !,
M         ( !OA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  "!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="abio-20221208.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="abio-20221208.htm">abio-20221208.htm</File>
    <File>abio-20221208.xsd</File>
    <File>abio-20221208_lab.xml</File>
    <File>abio-20221208_pre.xml</File>
    <File>abio-ex10_1.htm</File>
    <File>abio-ex10_2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "abio-20221208.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "abio-20221208.htm"
     ]
    },
    "labelLink": {
     "local": [
      "abio-20221208_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abio-20221208_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "abio-20221208.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "abio",
   "nsuri": "http://www.arcabiopharma.com/20221208",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "abio-20221208.htm",
      "contextRef": "C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "role": "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "abio-20221208.htm",
      "contextRef": "C_3c1572af-cc65-4da7-b6ec-03c3aa6d5266",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.arcabiopharma.com/20221208/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950170-22-026298-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-22-026298-xbrl.zip
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M'-4XVCT<U3ORU=BFT6W'M@/?IIH:N-2PF$KEYB,-3% ]7]&YK[K;V:8YYEQ
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M5SXJ#GXB\@.P%O8"(@IC>#'4?X4>=A;S08]<P@T3\E(ITF%IE\QE7R(>9'<
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MT):\7HZ:7L*''W\Z:G:S7O3Q_P%02P,$%     @ ^8&)5;V;5MD. P  LPD
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M^6V]&W!CL@>8$I:6[..XU[!VPAJAZU>SM.&;K6T$K=VN)?5-<_D74$L#!!0
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M($'4]PZ=R/!E+GYQ'D5;EY>79G0U#0VP*I#+6N:WQX=^E*?!GU#([QIJW)P
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MI1)!K_LA?&_Q\^9$GL'Q/YS<_ ]02P,$%     @ ^8&)5;J#F=*5!   ?"8
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M*\02VC.].65^4GLJ19 7ZB:]B;S $PD):[5C.+;MV#IQ%D*HI7VR8\#5?:$
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M2R@VH@FC<'/5:XJL>R?[PE2^+:!<&D\_G(HKI,J$R%91QDVA /=SHHD>&3G
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M !$              ( !     &%B:6\M,C R,C$R,#@N:'1M4$L! A0#%
M  @ ^8&)5;V;5MD. P  LPD  !$              ( !P18  &%B:6\M,C R
M,C$R,#@N>'-D4$L! A0#%     @ ^8&)5<#8EA.T!0  +S0  !4
M     ( !_AD  &%B:6\M,C R,C$R,#A?;&%B+GAM;%!+ 0(4 Q0    ( /F!
MB56Z@YG2E00  'PF   5              "  >4?  !A8FEO+3(P,C(Q,C X
M7W!R92YX;6Q02P$"% ,4    " #Y@8E5F@:20($+   I9   #P
M    @ &M)   86)I;RUE>#$P7S$N:'1M4$L! A0#%     @ ^8&)55>!"*9[
M"P  *&(   \              ( !6S   &%B:6\M97@Q,%\R+FAT;5!+!08
1    !@ & 'X!   #/      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
